You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Desmoplastic small round-cell tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumor, Desmoplastic Small Round Cell, Adult, Tumor, Desmoplastic Small Round Cell, Childhood, Sarcoma, Ewing Trial in Spain (nab

Completed
  • Tumor, Desmoplastic Small Round Cell, Adult
  • +4 more
  • nab paclitaxel
  • Barcelona, Spain
  • +6 more
Jun 6, 2022

Peritoneal Cancer Trial in New York (131 I-8H9)

Active, not recruiting
  • Peritoneal Cancer
  • 131 I-8H9
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 7, 2022

Ewing Sarcoma, Desmoplastic Small Round Cell Tumor, Pediatric Cancer Trial in Philadelphia (Lurbinectedin)

Not yet recruiting
  • Ewing Sarcoma
  • +3 more
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jun 27, 2023

Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)

Temporarily not available
  • Epithelioid Sarcoma (Ex-US Only)
  • +19 more
  • (no location specified)
Oct 17, 2022

Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)

Recruiting
  • Pediatric Solid Tumor
  • +15 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jun 30, 2022

Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small

Recruiting
  • Desmoplastic Small Round Cell Tumor
  • +11 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 26, 2022

Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

Recruiting
  • Pediatric Solid Tumor
  • +15 more
  • second generation 4-1BBζ EGFR806-EGFRt
  • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
  • Seattle, Washington
    Seattle Children's Hospital
May 2, 2022

Solid Tumor, Adult, Brain Tumor, Primary, Desmoplastic Small Round Cell Tumor Trial in Australia, Korea, Republic of, United

Recruiting
  • Solid Tumor, Adult
  • +2 more
  • Santa Monica, California
  • +11 more
Jul 27, 2022

Malignant Abdominal Tumor, Malignant Pelvic Tumor, Recurrent Colon Carcinoma Trial in Rochester (Cisplatin, Cytoreductive

Recruiting
  • Malignant Abdominal Neoplasm
  • +26 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023

Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma Trial in United States (Enoblituzumab)

Completed
  • Neuroblastoma
  • +5 more
  • Palo Alto, California
  • +5 more
Feb 4, 2022

Soft Tissue Sarcoma, Clear Cell Sarcoma, Epithelioid Sarcoma Trial in France (Patient with Soft Tissue Sarcoma)

Recruiting
  • Soft Tissue Sarcoma
  • +9 more
  • Patient with Soft Tissue Sarcoma
  • Besancon, France
  • +13 more
Oct 11, 2022

Desmoplastic Small Round Cell Tumor, Rhabdomyosarcoma Trial in New York (Prexasertib, Irinotecan)

Active, not recruiting
  • Desmoplastic Small Round Cell Tumor
  • Rhabdomyosarcoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 3, 2022

Desmoplastic Small Round Cell Tumor Trial in New York

Recruiting
  • Desmoplastic Small Round Cell Tumor
    • New York, New York
      Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    Jan 6, 2022

    Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle

    Completed
    Has Results
    • Adult Alveolar Soft Part Sarcoma
    • +18 more
    • Portland, Oregon
    • +1 more
    Sep 23, 2021

    Sarcoma, Desmoplastic Small Round Cell Tumor (DSRCT) Trial in New York (irinotecan, temozolomide, and bevacizumab incorporated

    Active, not recruiting
    • Sarcoma
    • Desmoplastic Small Round Cell Tumor (DSRCT)
    • irinotecan, temozolomide, and bevacizumab incorporated into an existing schedule of high dose alkylator
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Sep 1, 2021

    Desmoplastic Small Round Cell Tumor Trial in Worldwide (Ramucirumab, Cyclophosphamide, Vinorelbine)

    Active, not recruiting
    • Desmoplastic Small Round Cell Tumor
    • Phoenix, Arizona
    • +50 more
    Jan 18, 2023

    Soft Tissue Sarcoma, Bone Tumors, Small Round-cell Sarcomas Trial in Barcelona, Madrid, Tenerife (Trabectedin)

    Recruiting
    • Soft Tissue Sarcoma
    • +2 more
    • Barcelona, Cataluña, Spain
    • +6 more
    Nov 23, 2021

    Ewing Sarcoma, Myxoid Liposarcoma, Desmoplastic Small Round Cell Tumor Trial in Santa Monica (Seclidemstat)

    Enrolling by invitation
    • Ewing Sarcoma
    • +8 more
    • Santa Monica, California
      Sarcoma Oncology Center
    Feb 23, 2022

    NSCLC Trial in Shanghai (BL-M02D1)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Jul 10, 2023

    Small Cell Lung Cancer, Extra-Pulmonary Small Cell Carcinomas Trial run by the NCI (PLX038, Rucaparib)

    Active, not recruiting
    • Small Cell Lung Cancer
    • Extra-Pulmonary Small Cell Carcinomas
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)

    Recruiting
    • EGFR-Mutated Non-Small-Cell Lung Carcinoma
    • Small Cell/Neuroendocrine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Tumors Trial in Worldwide (GSK3901961, Cyclophosphamide, Fludarabine)

    Terminated
    • Neoplasms
    • New Haven, Connecticut
    • +20 more
    Sep 15, 2023

    Advanced Solid Tumor, Metastatic Solid Tumor, Lung Cancer Trial in Seoul, Incheon (WM-A1-3389, Pembrolizumab)

    Not yet recruiting
    • Advanced Solid Tumor
    • +7 more
    • WM-A1-3389
    • Pembrolizumab
    • Seoul, Seocho-gu, Korea, Republic of
    • +1 more
    May 14, 2023

    Carcinoma, Squamous Cell of Head and Neck, NSCLC, Ovarian Tumors Trial (disitamab vedotin)

    Not yet recruiting
    • Carcinoma, Squamous Cell of Head and Neck
    • +3 more
    • disitamab vedotin
    • (no location specified)
    Aug 15, 2023

    MTAP-null Non-Small-Cell Lung Cancer, MTAP-null Solid Tumors Trial (AMG 193, IDE397)

    Not yet recruiting
    • MTAP-null Non-Small-Cell Lung Cancer
    • MTAP-null Solid Tumors
    • (no location specified)
    Jul 27, 2023